Skip to content

Shoulder Abduction Brace Against Normal Sling After Arthroscopical Rotator Cuff Suture.

Shoulder Abduction Brace Against Normal Sling After Arthroscopical Rotator Cuff Suture: a Randomized Monocentric Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03445494
Enrollment
108
Registered
2018-02-26
Start date
2018-01-10
Completion date
2023-07-11
Last updated
2023-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraspinatus Injury

Brief summary

The patient undergoes arthroscopic surgery to treat rotator cuff injury. At the end of the surgery, the patient will be randomized into group A (brace) or group B (normal sling). Both groups will be also treated according to standard of care with physiotherapy and progressive introduction of movements.

Detailed description

The patient undergoes arthroscopic surgery to treat rotator cuff injury. At the end of the surgery, the patient will be randomized into group A (brace) or group B (normal sling). Both groups will then perform only passive movements according to pain for the first 6 weeks supported by the physiotherapy, according to standard therapy. The following six weeks passive movements will be associated with active movements . No brace nor normal sling will be used anymore. Patients are in study for 6 months. During this period quality of life and pain questionnaires are submitted to the patients and a MRI will be done at the end of the study.

Interventions

PROCEDUREBrace

A brace to be weared according to protocol

PROCEDURENormal sling

A normal sling to be weared according to protocol

Sponsors

Clinical Trial Unit Ente Ospedaliero Cantonale
CollaboratorOTHER
Christian Candrian
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

randomized 1:1

Eligibility

Sex/Gender
ALL
Age
18 Years to 72 Years
Healthy volunteers
No

Inclusion criteria

* Males or females between 18 and 65 years old; * Presence of an isolated lesion of supraspinatus that can be documented with the MRI and which can be treated surgically by arthroscopy; * Presence of a supraspinatus lesion according to the Patte criteria with stage 1, 2 or 3 frontal plane ; * Presence of adipose degeneration ≤ 2 according to Goutallier; * Written informed consent to participate in the study

Exclusion criteria

* Presence of a lesion of other rotator cuff tendons; * Previous surgical procedures of the shoulder; * Presence of a massive lesion, therefore irreparable, of the cuff detected intra-operatively and not observed during preoperative MRI; * Presence of relapsing shoulder dislocations; * Presence of lesions of the glenoidine cercine that require intervention; * Difficulties to follow the rehabilitation programs; * Presence of neoplastic diseases, metabolic diseases, inflammatory and systemic diseases, autoimmune diseases and immunosuppressed patients; * State of pregnancy (presumed or established) or breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy in the rehabilitative therapy6 monthsThe primary objective of the study is to evaluate two different rehabilitative therapies. Efficacy is measured with a pre and post MRI

Secondary

MeasureTime frameDescription
Quality of life assessment6 monthsEvaluation of the quality of live in both groups through Constant Quality of Life questionnair up to 6 months
re-rupture rate of the supraspinatus tendon6 monthsEvaluation of the re-rupture of the supraspinatus tendon though a follow up MRI at 6 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026